IP Library Patent Application 17100710
Patent Application
App. No. 17/100,710

SYSTEMS AND METHODS FOR DETERMINING INSULIN THERAPY FOR A PATIENT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/100,710
Abstract

In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.

Claims (35)

1 . A non-transitory computer readable medium having stored therein instructions executable by a computing device to cause the computing device to perform functions comprising:

receive a selection from a user of an insulin dosing model;

prompt the user to provide information specific to a patient based on the selection;

generate an insulin dosage recommendation based on the selection and the information specific to the patient; and

provide a graphical user interface customized to the insulin dosing model and configured to display the insulin dosage recommendation to the user.

2 . The non-transitory computer readable medium of claim 1 , wherein the insulin dosing model comprises an intravenous insulin dosing model and the insulin dosage recommendation comprises an intravenous insulin dosage recommendation.

3 . The non-transitory computer readable medium of 2 , wherein the information specific to the patient comprises a current insulin infusion rate and a glucose measurement used to determine the current insulin infusion rate.

4 . The non-transitory computer readable medium of claim 1 , wherein the insulin dosing model comprises a subcutaneous insulin dosing model and the insulin dosage recommendation comprises a subcutaneous insulin dosage recommendation.

5 . The non-transitory computer readable medium of claim 4 , wherein the information specific to the patient comprises a total basal insulin units administered per day and a total bolus insulin units administered per day.

6 . The non-transitory computer readable medium of claim 1 , wherein the insulin dosing model comprises a starting insulin dosing model and the insulin dosage recommendation comprises an intravenous insulin dosage recommendation or a subcutaneous insulin dosage recommendation.

7 . The non-transitory computer readable medium of claim 6 , wherein the information specific to the patient comprises demographic information and clinical information.

8 . The non-transitory computer readable medium of claim 1 , wherein the information specific to the patient comprises a diabetes diagnosis, a potassium level, a weight, a targeted blood glucose range, a creatinine level, a date of birth, a sex, or combinations thereof.

9 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:

receive additional information specific to the patient from a hospital information system communicatively coupled to the computing device.

10 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:

disseminate an order embodying the insulin dosage recommendation to various locations within a hospital equipped to execute the order.

11 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:

receive a current glucose level from a continuous glucose monitor connected to the patient.

12 . The non-transitory computer readable medium of claim 1 , wherein the insulin dosage recommendation is executable by an insulin delivery device.

13 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:

generate a carbohydrate dosage recommendation based at least in part on the information specific to the patient.

14 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:

generate an instruction indicating when a next glucose measurement should be obtained.

15 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:

cause the graphical user interface to display a request for additional information, a therapy recommendation, or both when an unexpected glucose value is measured after the insulin dosage recommendation is implemented.

16 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:

cause the graphical user interface to display a first interface when the insulin dosing model comprises an intravenous insulin doing model and a second interface, different from the first, when the insulin dosing model comprises a subcutaneous insulin dosing model.

17 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:

receive a selection of a hospital and a selection of a unit within the hospital where the patient is located.

18 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:

determine that a most recent glucose measurement was received longer than a maximum length of time before a current time,

wherein the insulin dosing model comprises a restarting insulin dosing model.

19 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to further perform functions comprising:

generate an alert for visual display or audible transmission to the user when a glucose check is past due.

20 . The non-transitory computer readable medium of claim 1 , wherein the instructions are executable to cause the computing device to operate without connecting to a server or a hospital information system.

Assignments (3)
SECURITY INTEREST Recorded Dec 18, 2025
From: MONARCH MEDICAL TECHNOLOGIES, LLC
To: VISTARA TECHNOLOGY GROWTH FUND V MASTER, LP, AS AGENT
Reel/Frame 073263/0668 →
SECURITY INTEREST Recorded Nov 5, 2025
From: MONARCH MEDICAL TECHNOLOGIES, LLC
To: STIFEL BANK
Reel/Frame 072797/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2020
From: RUCHTI, TIMOTHY L.; BURGESS, WILLIAM PATRICK; DUMAS, JOHN; LISIECKI, RONALD; MARTIN, CAROL DIAN; SANTANA, LAURA; THORNLEY, JOHN HARRISON; WATT, JOANNE MARIE
To: MONARCH MEDICAL TECHNOLOGIES, LLC
Reel/Frame 054437/0400 →